Clinical Trial Update: Comparison of Biodegradable Stents: Orsiro and BioMatrix [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Orsiro and BioMatrix biodegradable polymer drug-eluting stents in all-comer patients undergoing percutaneous coronary intervention has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Biomatrix
• Orsiro (Sirolimus-eluting stent)

Snippet

Sponsor: Yonsei University | Conditions: All-comer, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED